Expedeon AG: Expedeon AG information on EUR 120 million deal with Abcam on dedicated transaction website (news with additional features)
DGAP-News: Expedeon AG
/ Key word(s): Miscellaneous
Expedeon AG information on EUR 120 million deal with Abcam on dedicated transaction website
Heidelberg, Germany and Cambridge, UK, 20 November 2019 - Expedeon AG (Frankfurt: EXNN; ISIN: DE000A2YN801; Prime Standard) announced today that it has made information available on a dedicated website relating to the transaction agreement with Abcam plc (London Stock Exchange: ABC; ISIN: GB00B6774699; AIM MTF), Cambridge, UK.
On November 11, 2019 Expedeon announced the sale of its proteomics and immunology business activities for a cash payment of EUR 120 million. The agreement is subject to shareholder approval at an extraordinary general meeting to be held in Heidelberg on December 19th, 2019. The website also provides the relevant shareholder information.
The website is accessible at http://transaction.expedeon.com. Visitors will be asked to register.
For further information, please contact:
MC Services AG (Investor Relations and International Media Relations)
About Expedeon AG: www.investors.expedeon.com
### This publication is intended for information only and constitutes neither an offer to sell nor an invitation to buy securities. Some statements included in this press release, relating neither to proven financial results nor other historical data, should be viewed as forward-looking, i.e. not definite. Such statements are mainly predictions of future results, trends, plans or goals. These statements should not be considered to be total guarantees since given their very nature they are subject to known and unknown risks and imponderability and can be affected by other factors as a consequence of which the actual results, plans and goals of Expedeon AG may deviate greatly from the established conclusions or implied predictions contained in such statements. Expedeon does not undertake to publicly update or revise these statements in the light of new information or future results or for any other reason. ###
Document title: Web_Eng
20.11.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
|Waldhofer Str. 102|
|Phone:||+49 (0) 6221 3540 125|
|Fax:||+49 (0) 6221 3540 127|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||916825|
|End of News||DGAP News Service|